Showing results (11-20 of 98) with videos related to
Sort By:
Pageof 10
Journal of Cardiovascular Pharmacology|February 28, 2002
Alterations of the nitric oxide pathway in cerebral arteries from spontaneously hypertensive ratsAna M Briones, María J Alonso, Raquel Hernanz, et al.Journal of Hypertension|March 19, 2005
Hypertension increases the participation of vasoconstrictor prostanoids from cyclooxygenase-2 in phenylephrine responsesYolanda Alvarez, Ana M Briones, Gloria Balfagón, et al.American Journal of Physiology. Heart and Circulatory Physiology|March 6, 2004
Hypertension alters role of iNOS, COX-2, and oxidative stress in bradykinin relaxation impairment after LPS in rat cerebral arteriesRaquel Hernanz, Ana M Briones, María J Alonso, et al.Molecular Interventions|March 29, 2011
NOX isoforms and reactive oxygen species in vascular healthRhian M Touyz, Ana M Briones, Mona Sedeek, et al.Scanning|January 30, 2004
Confocal microscopic image sequence compression using vector quantization and three-dimensional pyramidW Paul Cockshott, Yegang Tao, Gang Gao, et al.British Journal of Pharmacology|October 10, 2003
Mechanisms involved in the early increase of serotonin contraction evoked by endotoxin in rat middle cerebral arteriesRaquel Hernanz, Maria J Alonso, Ana M Briones, et al.Life Sciences|August 15, 2002
Hypertension alters the participation of contractile prostanoids and superoxide anions in lipopolysaccharide effects on small mesenteric arteriesAna M Briones, María J Alonso, Raquel Hernanz, et al.The Journal of Pharmacology and Experimental Therapeutics|September 27, 2005
Increased superoxide anion production by interleukin-1beta impairs nitric oxide-mediated relaxation in resistance arteriesFrancesc Jiménez-Altayó, Ana M Briones, Jesús Giraldo, et al.Frontiers in Pharmacology|March 7, 2019
G Protein-Coupled Receptor Kinase 2 (GRK2) as a Potential Therapeutic Target in Cardiovascular and Metabolic DiseasesCristina Murga, Alba C Arcones, Marta Cruces-Sande, et al.Biomolecules|October 17, 2019
Emerging Roles of Lysyl Oxidases in the Cardiovascular System: New Concepts and Therapeutic ChallengesJosé Martínez-González, Saray Varona, Laia Cañes, et al.Pageof 10